Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 400,405 | 370,091 | 338,941 | 320,526 | 294,136 |
| Cost of Goods | 51,358 | 39,377 | 35,269 | 33,147 | -20,191 |
| Gross Profit | 349,047 | 330,714 | 303,672 | 287,379 | 314,327 |
| Operating Expenses | 214,130 | 193,400 | 186,969 | 179,650 | 171,417 |
| Operating Income | 135,275 | 137,691 | 116,972 | 107,876 | 142,719 |
| Interest Expense | 1,078 | 1,056 | 1,171 | 1,181 | 1,855 |
| Other Income | 91 | 628 | 940 | 575 | -99 |
| Pre-tax Income | 134,288 | 137,263 | 116,741 | 107,270 | 140,765 |
| Income Tax | 40,503 | 41,378 | 34,524 | 26,298 | 48,586 |
| Net Income Continuous | 93,785 | 95,885 | 82,217 | 80,972 | 92,179 |
| Net Income | $93,785 | $95,885 | $82,217 | $80,972 | $92,179 |
| EPS Basic Total Ops | 0.48 | 0.49 | 0.42 | 0.43 | 0.48 |
| EPS Basic Continuous Ops | 0.48 | 0.49 | 0.42 | 0.42 | 0.48 |
| EPS Diluted Total Ops | 0.47 | 0.48 | 0.41 | 0.41 | 0.46 |
| EPS Diluted Continuous Ops | 0.47 | 0.48 | 0.41 | 0.41 | 0.46 |
| EBITDA(a) | $143,054 | $144,464 | $123,238 | $114,150 | $175,213 |